Literature DB >> 433674

Mycoplasma pneumoniae infection associated with affection of the central nervous system.

K Lind, H Zoffmann, S O Larsen, O Jessen.   

Abstract

A total of 371 patients with acute, febrile, non-bacterial affection of the CNS hospitalized between Nov. 1, 1971, and June 1, 1976, were examined for Mycoplasma (M.) pneumoniae infection. Nineteen of the patients showed evidence of a current M. pneumoniae infection, 32 of a previous infection, and 320 no evidence. In patients with a current infection due to M. pneumoniae, suggestive evidence is presented that this agent might be involved in the pathogenesis of the neurological syndromes. Compared to cases without the infection, these cases and, to a lesser degree, those with a previous M. pneumoniae infection showed an increased frequency of pathological values, found by various laboratory and instrumental parameters, and a slightly higher frequency of neurological sequelae. Respiratory illness was present in only 11 of the 19 patients infected with M. pneumoniae, a classical respiratory tract pathogen. The overall incidence of current M. pneumoniae infections among patients with neurological syndromes was 5%, with a maximum of 10% during the 1972 epidemic. This is a much higher figure than expected from a mere coincidence of the two conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433674     DOI: 10.1111/j.0954-6820.1979.tb06057.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  14 in total

Review 1.  Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia.

Authors:  K Gücüyener; F Simşek; O Yilmaz; A Serdaroğlu
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

2.  Severe Mycoplasma disease--rare or underdiagnosed?

Authors:  G H Cassell
Journal:  West J Med       Date:  1995-02

3.  The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period.

Authors:  A C Vu; H M Foy; F D Cartwright; G E Kenny
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

4.  Mycoplasma pneumoniae protein involved in the antibody response in human infection.

Authors:  S Räisänen; J I Suni; A Vaheri
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

5.  Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings.

Authors:  E Maida
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

6.  Cytadsorption of Mycoplasma pulmonis to rat ependyma.

Authors:  D F Kohn; N Chinookoswong
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

7.  Pathogenicity of Mycoplasma pulmonis in ependymal organ culture.

Authors:  D F Kohn; N Chinookoswong
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

Review 8.  Manifestations and complications of Mycoplasma pneumoniae disease: a review.

Authors:  K Lind
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec

9.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28

Review 10.  Epidemiologic aspects of M. pneumoniae disease complications: a review.

Authors:  H M Foy; C M Nolan; I D Allan
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.